Hussein Y. Naimis
Professor
Biochemistry and Molecular Virology
Lebanese American University
Switzerland
Biography
Hussein Y. Naimis a Lebanese-Swiss Biochemist and Molecular Virologist, known for his research in Cell and Molecular Biology (membrane protein processing, sorting and endocytosis), Virology and Vaccinology (Semliki Forest, Measles, SARS, Human Immunodeficiency and Influenza viruses). He has more than twenty five years of experience in the fields of Vaccine discovery, Virology and Immunology, Molecular and Cell Biology, inAcademia and Industry. He held several leading positions at prominent universities and biotechnology centers. He has received his Ph.D. degree in Biochemistry from the University of Bern, Switzerland in 1989. He won a postdoctoral fellowship from the Swiss National Science foundation, and then became a faculty member at the University of Texas; Southwestern Medical Center at Dallas, USA. His research was instrumental towards understanding the molecular mechanisms of membrane proteins sorting and assembly of significant human viruses in epithelial cells. He was appointed a faculty member at the institute of molecular biology of the University of Zurich, Switzerland. His research focused on the development of novel live viral vectors and cancer therapy (virotherapy) that led to translating his research towards clinical applications. He transferred the technology to Biotech where he lead the live viral vectors department at Berna Biotech, then became the director of vaccine research at Crucell, Bern Switzerland. He spent a visiting professorship at the Lebanese American University before becoming Executive Consultant on Life Sciences and Vaccines for private Biopharma, Biotech industries and Academic Institutions. His research was awarded several competitive grants from the NIH and the European commission. He is a well-known pioneer in his field of expertise, with a broad spectrum of highly cited publications.He is an experienced advisor and trainer,and on board of international vaccine and gene therapy committees.
Research Interest
Vaccines and Vaccination Programs; Viral Vectors; Cancer and Immunotherapy; Cancer Prevention.
